Table 2.
Number or Value | |
---|---|
Diagnoses | |
Pancreatic ductal adenocarcinoma | 26 |
Common bile duct adenocarcinoma | 10 |
Intraductal papillary mucinous neoplasia | 1 |
Serous cystic neoplasia | 1 |
Pancreatic neuroendocrine tumor | 5 |
Chronic pancreatitis | 2 |
Tumor stage (n = 41)a | |
1 | 0 |
2 | 2 |
3 | 39 |
4 | 0 |
Lymph node status (positive/negative) n = 41 | 30/11 |
Lymph node ratio (<0,2/≥0,2) n = 41 | 23/18 |
Tumor size, mm; mean (±SD) | 45 ± 37 |
R-status (R0/R1), n = 41 | 15/26 |
Recurrence (yes/no), n = 41 | 30/11 |
Site of recurrence | |
Local only | 13 |
Distant only | 8 |
Local and distant | 9 |
Survival, PDAC, months; median (IQR) | 17 (13–31) |
Survival, CBDCa, months; median (IQR) | 17 (5–27) |
Disease-free survival, PDAC, months; median (IQR) | 12 (8–17.5) |
Disease-free survival, CBDCa, months; median (IQR) | 9 (4–21) |
Follow-up, entire study population, months; median (IQR) | 13 (7–30) |
Time to last CT, months; median (IQR) | 8 (4.5–16.5) |
UICC, TNM classification of malignant tumors. 7th. Ed. Oxford:Wiley-Blackwell, 2009.